Insider · CIK 0001204059

THURMAN RANDY H

Reports to the SEC for 9 companies · ISELIN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001204059

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-26	OTLKOutlook Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$0.43	+$2,145	5,593
2025-10-01	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+287K sh	—	—	286,734
2024-10-01	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+56.6K sh	—	—	56,636
2024-10-01	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+89.5K sh	—	—	89,549
2024-03-07	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+94.4K sh	—	—	94,441
2023-03-29	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+41.1K sh	—	—	41,065
2022-09-29	TFF Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+40.3K sh	$2.50	+$101K	40,255
2022-09-29	TFF Pharmaceuticals, Inc.S Sale	Director	SSale	−40.3K sh	$4.29	−$173K	0
2022-09-29	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−40.3K sh	—	—	84,670
2022-03-23	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+81.9K sh	—	—	81,878
2021-05-18	TFF Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+1,050 sh	$9.40	+$9,870	1,050
2021-03-24	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.9K sh	—	—	20,873
2020-11-13	TFF Pharmaceuticals, Inc.S Sale	Director	SSale	−5,000 sh	$17.17	−$85.9K	0
2020-11-11	TFF Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+34.5K sh	$2.50	+$86.3K	39,504
2020-11-11	TFF Pharmaceuticals, Inc.S Sale	Director	SSale	−34.5K sh	$15.91	−$549K	5,000
2020-11-11	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−34.5K sh	—	—	124,925
2020-10-05	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+397K sh	$0.51	+$204K	396,809
2020-10-01	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+259K sh	—	—	259,297
2020-09-14	OTLKOutlook Therapeutics, Inc.P Purchase	Director	PPurchase	+10K sh	$0.62	+$6,200	11,875
2020-08-24	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+20K sh	—	—	159,429
2020-07-17	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+155K sh	—	—	154,555
2020-07-17	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+210K sh	—	—	210,000
2020-03-19	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-11-29	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+3,623 sh	—	—	139,429
2019-10-29	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+43.8K sh	—	—	135,806
2019-10-25	TFF Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+5,000 sh	$5.00	+$25K	5,000
2019-10-03	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-10-03	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+207K sh	$0.99	+$204K	207,036
2018-12-21	OTLKOutlook Therapeutics, Inc.P Purchase	Director	PPurchase	+15K sh	$0.68	+$10.3K	15,000
2018-11-09	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+568K sh	$0.61	+$348K	567,522
2018-09-21	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-06-27	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2018-04-13	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-05-22	Veradigm Inc.A Award	Director	AAward	+16.8K sh	—	—	105,014
2017-03-13	Presbia PLCA Award	Director, Executive Chairman	AAward	+12.7K sh	—	—	45,924
2017-03-08	Presbia PLCX Exercise of In-Money	Director, Executive Chairman	XExercise of In-Money	+5,543 sh	$3.00	+$16.6K	33,186
2017-03-08	Presbia PLCSubscription Rights (right to buy)X Exercise of In-Money	Director, Executive Chairman	XExercise of In-Money	−16.5K sh	—	—	0
2016-08-05	Presbia PLCA Award	Director, Executive Chairman	AAward	+8,247 sh	—	—	27,643
2016-05-24	Veradigm Inc.A Award	Director	AAward	+15.1K sh	—	—	88,249
2015-11-25	Presbia PLCP Purchase	Director, Executive Chairman	PPurchase	+1,833 sh	$5.45	+$9,989.85	1,833
2015-08-03	Presbia PLCJ Other	Director, Executive Chairman	JOther	+8,286 sh	—	—	19,396
2015-05-29	Veradigm Inc.A Award	Director	AAward	+14.2K sh	—	—	73,120
2015-05-20	Presbia PLCP Purchase	Director, Executive Chairman	PPurchase	+11.1K sh	$8.96	+$99.5K	11,110
2014-11-11	Veradigm Inc.P Purchase	Director	PPurchase	+8,849 sh	$11.29	+$99.9K	58,905
2014-01-24	Arno Therapeutics, IncStock Option (right to buy)A Award	Director	AAward	+34.2K sh	—	—	34,224
2013-11-05	OFIXOrthofix Medical Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2013-11-04	Arno Therapeutics, IncStock Option (right to buy)A Award	Director	AAward	+68.4K sh	—	—	68,448
2013-05-22	Arno Therapeutics, IncP Purchase	Director	PPurchase	+2,500 sh	$0.50	+$1,250	10,000
2013-05-21	Veradigm Inc.A Award	Director	AAward	+14.2K sh	—	—	36,524
2013-05-21	Arno Therapeutics, IncP Purchase	Director	PPurchase	+7,500 sh	$0.50	+$3,750	7,500

Recent filings

Accepted (ET)
May 274
THURMAN RANDY H0001649989-26-000002
SEC(opens sec.gov)
Oct 34
THURMAN RANDY H0001649989-25-000004
SEC(opens sec.gov)
Oct 34
THURMAN RANDY H0001415889-24-024701
SEC(opens sec.gov)
Mar 84
THURMAN RANDY H0001415889-24-007319
SEC(opens sec.gov)
Mar 314
THURMAN RANDY H0001209191-23-021905
SEC(opens sec.gov)
Sep 304
THURMAN RANDY H0001213900-22-060782
SEC(opens sec.gov)
Mar 244
THURMAN RANDY H0001209191-22-020949
SEC(opens sec.gov)
May 194
THURMAN RANDY H0001213900-21-027899
SEC(opens sec.gov)
Mar 264
THURMAN RANDY H0001209191-21-023279
SEC(opens sec.gov)
Nov 134
THURMAN RANDY H0001213900-20-037060
SEC(opens sec.gov)
Oct 54
THURMAN RANDY H0001209191-20-053870
SEC(opens sec.gov)
Sep 174/A
THURMAN RANDY H0001209191-20-051048
SEC(opens sec.gov)
Sep 154
THURMAN RANDY H0001209191-20-050564
SEC(opens sec.gov)

Companies

Address

C/O OUTLOOK THERAPEUTICS, INC. 111 S. WOOD AVE, UNIT #100

ISELIN, NJ, 08830